Series A funding round for Ascend Gene & Cell Therapies raising $66M in May 2023
Series A funding round for Ascend Gene & Cell Therapies raising $66M in May 2023
| Investor | Firm Type | Partner |
|---|
AbingworthLEAD | Venture Capital | — |
PetrichorLEAD | Venture Capital | — |
| Venture Capital | — | |
| Private Equity | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Venture Capital | — | |
| Angel | Ed Mathers |
This company has completed 1 funding round. Current round is highlighted.
Total Raised
$66M
Top Valuation
-
Ascend Gene & Cell Therapies raised $66M in a Series A round.
The round was announced on 05/01/23.
The round was led by Abingworth, Michael Beecham.